Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 526

The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.

Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association

Giri, Jay, Sista, Akhilesh K., Weinberg, Ido, Kearon, Clive, Kumbhani, Dharam J., Desai, Nimesh D., Piazza, Gregory, Gladwin, Mark T., Chatterjee, Saurav, Kobayashi, Taisei, Kabrhel, Christopher, Barnes, Geoffrey D., On behalf of the American Heart Association Council on Peripheral Vascular Disease; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; and Council on Cardiovascular Surgery and Anesthesia·2019·Circulation

Abstract

Pulmonary embolism (PE) represents the third leading cause of cardiovascular mortality. The technological landscape for management of acute intermediate- and high-risk PE is rapidly evolving. Two interventional devices using pharmacomechanical means to recanalize the pulmonary arteries have recently been cleared by the US Food and Drug Administration for marketing, and several others are in various stages of development. The purpose of this document is to clarify the current state of endovascular interventional therapy for acute PE and to provide considerations for evidence development for new devices that will define which patients with PE would derive the greatest net benefit from their use in various clinical settings. First, definitions and limitations of commonly used risk stratification tools for PE are reviewed. An adjudication of risks and benefits of available interventional therapies for PE follows. Next, considerations for optimal future evidence development in this field are presented in the context of the current US regulatory framework. Finally, the document concludes with a discussion of the pros and cons of the rapidly expanding PE response team model of care delivery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/cir.0000000000000707

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 106 references

Cited by

See all 526

Metadata

Authors
Giri, J., Sista, A. K., Weinberg, I., Kearon, C., Kumbhani, D. J., Desai, N. D., Piazza, G., Gladwin, M. T., Chatterjee, S., Kobayashi, T., Kabrhel, C., Barnes, G. D., & On behalf of the American Heart Association Council on Peripheral Vascular Disease; Council on Arteriosclerosis, T. A. V. B. C. O. C.
Venue
Circulation
Published
2019-11-12
Volume
140
Issue
20
Pages
e774-e801
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2978905037
Cited by
526
References
106
FWCI
29.95
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association. https://app.cochat.ai/papers/10.1161/cir.0000000000000707
The paper
Giri, J., Sista, A. K., Weinberg, I., Kearon, C., Kumbhani, D. J., Desai, N. D., Piazza, G., Gladwin, M. T., Chatterjee, S., Kobayashi, T., Kabrhel, C., Barnes, G. D., & On behalf of the American Heart Association Council on Peripheral Vascular Disease; Council on Arteriosclerosis, T. A. V. B. C. O. C. (2019). Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association. Circulation. https://doi.org/10.1161/cir.0000000000000707

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.